Search For Similarity Regulatory Considerations Of Drug Abuse Potential Investigations

This article focuses on FDA and EMA regulatory guidelines surrounding drug abuse/dependence and abuse potential investigations, particularly in...

Related Keywords

New York , United States , Japan , American , Johnf Kelly , Clin Neurosci , Anke Rosch , Jarolimekw Sridhar , Richard Saitz Sarah Wakeman , Nat Neurosci , Expert Committee On Addiction , Boehringer Ingelheim , Japan Pharmaceutical Manufacturers Association , Office Of Drugs , Intj Environ Res Public Health , European Medicine Agency , Committee For Proprietary Medicinal Products , American Psychiatric Association Ed , Eaton , Us Department Of Health , Drug Enforcement Administration , Human Services , European Commission , World Health Organization , Drug Administration , United Nations , World Health Organisation , Diversion Control Division , Narcotics Division , Committee For Medicinal Products Human , Devices Agency , Us Department Of Justice , International Perspective , World Health Organ Tech Rep Ser , Central Asia , Proprietary Medicinal Products , Abuse Potential , Animal Studies , Clinical Observations , Drug Dependence , Penetration Of The Blood Brain , World Drug Report , Drug Report , Selective Serotonin Uptake Inhibitors , Medicinal Products , Human Use , Dependence Potential , Drug Evaluation , Medical Devices , Pharmaceutical Manufacturers , Pharmaceutical Regulations , Health Organization , World Health , Edition Volume , Health Organisation Retrieved , Psychiatric Association , American Psychiatric Publishing , World Health Organ Tech Rep , Richard Saitz , Sarah Wakeman , Substance Use Disorders , Alcoholism Treatment Quarterly , Chemical Evaluation , Basic Science , Loperamide Abuse , Ann Emerg , Safety Communication , Brain To Plasma Partition Coefficient , Game Changing Parameter , Pharmacol Exp , Pharmacological Similarity , Newly Identified Drugs , Clin Pharmacol , Expert Opin Drug , Rev Drug , Van Vleet , Pharmacol Toxicol , Substance Abuse During , Safety Testing , Drug Metabolites Guidance ,